Teleflex Incorporated $TFX Shares Sold by Y Intercept Hong Kong Ltd

Y Intercept Hong Kong Ltd lowered its position in Teleflex Incorporated (NYSE:TFX) by 74.8% in the first quarter, Holdings Channel reports. The fund owned 2,835 shares of the medical technology company’s stock after selling 8,402 shares during the period. Y Intercept Hong Kong Ltd’s holdings in Teleflex were worth $339,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the company. AQR Capital Management LLC increased its position in shares of Teleflex by 478.1% in the 3rd quarter. AQR Capital Management LLC now owns 2,366,131 shares of the medical technology company’s stock valued at $287,603,000 after purchasing an additional 1,956,811 shares during the last quarter. Norges Bank purchased a new stake in shares of Teleflex during the 4th quarter worth $66,076,000. Wolf Hill Capital Management LP purchased a new stake in shares of Teleflex during the 4th quarter worth $47,405,000. Arrowstreet Capital Limited Partnership grew its stake in shares of Teleflex by 123.9% during the third quarter. Arrowstreet Capital Limited Partnership now owns 660,800 shares of the medical technology company’s stock worth $80,855,000 after purchasing an additional 365,663 shares in the last quarter. Finally, Pzena Investment Management LLC grew its stake in shares of Teleflex by 84.2% during the first quarter. Pzena Investment Management LLC now owns 699,125 shares of the medical technology company’s stock worth $83,622,000 after purchasing an additional 319,660 shares in the last quarter. Institutional investors and hedge funds own 95.62% of the company’s stock.

Teleflex Trading Down 4.6%

Shares of Teleflex stock opened at $130.07 on Wednesday. The company has a fifty day simple moving average of $130.21 and a 200-day simple moving average of $120.23. Teleflex Incorporated has a 12-month low of $100.18 and a 12-month high of $139.67. The company has a current ratio of 2.55, a quick ratio of 2.03 and a debt-to-equity ratio of 0.82. The stock has a market cap of $5.76 billion, a price-to-earnings ratio of -5.70, a PEG ratio of 1.01 and a beta of 0.82.

Teleflex (NYSE:TFX) last posted its earnings results on Thursday, May 7th. The medical technology company reported $1.39 EPS for the quarter, beating analysts’ consensus estimates of $1.21 by $0.18. Teleflex had a negative net margin of 35.88% and a positive return on equity of 13.29%. The firm had revenue of $548.30 million for the quarter, compared to the consensus estimate of $536.91 million. During the same period last year, the firm posted $1.44 EPS. The company’s revenue was up 32.3% on a year-over-year basis. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. On average, equities analysts forecast that Teleflex Incorporated will post 6.7 EPS for the current fiscal year.

Teleflex Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 30th. Shareholders of record on Monday, May 25th were issued a dividend of $0.34 per share. The ex-dividend date of this dividend was Friday, May 22nd. This represents a $1.36 annualized dividend and a dividend yield of 1.0%. Teleflex’s dividend payout ratio (DPR) is presently -5.96%.

Analyst Ratings Changes

Several equities analysts recently commented on TFX shares. BMO Capital Markets started coverage on Teleflex in a report on Wednesday, July 8th. They issued an “outperform” rating and a $159.00 target price on the stock. Truist Financial reaffirmed a “hold” rating and set a $143.00 price target (up from $135.00) on shares of Teleflex in a report on Monday, May 11th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Teleflex in a research report on Wednesday, June 24th. Zacks Research upgraded Teleflex from a “strong sell” rating to a “hold” rating in a report on Tuesday, April 28th. Finally, Raymond James Financial reiterated an “outperform” rating and issued a $150.00 price objective on shares of Teleflex in a report on Friday, May 8th. One investment analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and an average price target of $147.44.

Teleflex Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.